Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: Differences between Chinese women and women in Western countries and possible mechanisms

Food Science and Human Wellness

Volumn 2, Issue 3-4, 2013, Pages 146-161

  He, FenJin ^a   Chen, Jin Qiang ^b,c  

^a Nature Soy Inc   (United States)

^b Science Writing Solutions   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer incidence; Genistein; Soy foods; Soy isoflavones; Soybean

Indexed keywords

EID: 85068978502     PISSN: None     EISSN: 22134530     Source Type: Journal    
DOI: 10.1016/j.fshw.2013.08.002     Document Type: Review

References (121)

1. Ziegler, R.G., Anderson, W.F., Gail, M.H., Increasing breast cancer incidence in China: the numbers add up. J. Natl. Cancer Inst. 100:19 (2008), 1339–1341.
2. Murtaugh, M.A., Sweeney, C., Giuliano, A.R., Herrick, J.S., Hines, L., Byers, T., Baumgartner, K.B., Slattery, M.L., Diet patterns and breast cancer risk in Hispanic and non-Hispanic white women: the Four-Corners Breast Cancer Study. Am. J. Clin. Nutr. 87:4 (2008), 978–984.
3. Perry, C.S., Otero, J., Palmer, J.L., Gros, A.S., Risk factors for breast cancer in East Asian women relative to women in the West. Asia-Pacific J. Clin. Oncol. 5:4 (2009), 219–231.
4. Qiu, L.-J., Chang, R.-Z., The origin and history of soybean. Singh, G., (eds.) The Soybean: Botany, Production and Uses, 2009, CABI Publishing.
5. Li, Y., Guan, R., Liu, Z., Ma, Y., Wang, L., Li, L., Li, F., Luan, W., Chen, P., Yan, P., Yan, G., Zhu, Y.L., Ning, X., Smulders, M.J.M., Li, M., Piao, R., Cui, Y., Yu, Z., Guang, M., Chang, R., Hou, A., Shi, A., Zhang, B., Zhu, S., Qiu, L., Genetic structure and diversity of cultivated soybean (Glycine max (L.) Merr.) landraces in China. Theor. Appl. Genet. 117 (2008), 857–871.
6. Soybean History at a Glance. 2013, Illinois soybean Association www.ilsoy.org.
7. World Agricultural Production, Circular Series WAP 12-12. December 2012, United States Department of Agriculture.
8. Orf, J.H., Selecting Soybean Varieties for Composition. 2013, Department of Agronomy and Plant Genetics, University of Minnesota.
9. National Nutrient Database for Standard Reference, Release 25. 2013, National Agricultural Library, USDA Agricultural Service.
10. 2010 Dietary Guidelines for Americans. December 2010, U.S. Department of Agriculture & U.S. Department of Health and Human Services.
11. Zambiazi, R.C., Przybylsk, R., Zambiazi, M.W., Mendonca, C.B., Fatty acid composition of vegetable oils and fats. B. CEPPA, Curitiba 25:1 (2007), 111–120.
12. Hoffman, J.R., Falvo, M.J., Protein – which is best?. J. Sports Sci. Med. 3 (2004), 118–130.
13. Dietary Protein Quality Evaluation in Human Nutrition – Report of an FAO Expert Consultation. FAO Food and Nutrition Paper 92., 2013 ISSN 0254-4725.
14. Anderson, J.W., Johnstone, B.M., Cook-Newell, M.E., Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333 (1995), 276–282.
15. Crouse, J.R. III, Morgan, T., Terry, T.G., Ellis, J., Vitolins, M., Burke, G.L., A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch. Intern. Med. 159:17 (1999), 2070–2076.
16. Sitori, C.R., Gianazza, E., Manzoni, C., Lovati, M.R., Murphy, P.A., Role of isoflavones in the cholesterol reduction of soy proteins in the clinic. Letter to the editor. Am. J. Clin. Nutr. 65 (1997), 166–167.
17. Food and Drug Administration, Food Labeling: Health Claims; Soy protein and Coronary Heart Disease. Federal Register/Rules and Regulations, vol. 64 (64), October 26, 1999.
18. Hermansen, K.B., Dinesen, L.H., Hoie, E., Morgenstern, J., Gruenwald, Effects of soy and other natural products on LDL:HDL ratio and other lipid parameters: a literature review. Adv. Ther. 20:1 (2003), 50–78.
19. Sacks, F.M., Lichtenstein, A., Van Horn, L., Harris, H.W., Kris-Etherton, P., Winston, M., Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113:7 (2006), 1034–1044.
20. Webb, D., Shedding light on soy. Today's Dietitian, 12(11), 2010, 28.
21. “Sales and Trends” from Soyfoods Association of North America. 2013 http://www.soyfoods.org/soy-information/sales-and-trends.
22. 18th Annual Consumer Attitudes about Nutrition – Insights into Nutrition, Health and Soyfoods. 2011 edition, 2013, United Soybean Board.
23. USDA Approves Soy Products for Full Use in School Lunch Programs Effective. April 2013 http://www.grainnet.com/articles/usda_approves_soy_products_for_full_use_in_school_lunch_programs_effective_april_10-6351.html.
24. Lazor, K., Chapman, N., Levine, E., Soy goes to school: acceptance of healthful, vegetarian options in Maryland middle school lunches. J. Sch. Helath 80:4 (2010), 200–206.
25. Crediting Tofu and Soy Yogurt Products. A memorandum issued by USDA Child Nutrition Division. 2012.
26. M. Messina, J.W. Erdman, Jr. (Guest Editors), in: First International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Proceedings from a Symposium Held in Mesa, Arizona on February 20–23, 1994, J. Nutr. Suppl., 1995.
27. Messina, M., Watanabe, S., Setchell, K.D.R., Report on the 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment. J. Nutr.(Suppl.), 2009, 796S–802S.
28. Oilseeds: World Markets and Trade. Circular Series FOP 045-13. May 2013, Foreign Agricultural Service, United States Department of Agriculture.
29. Soybean Oil and Biodiesel Usage Projections and Balance Sheet. 2013, Agricultural Marketing Resource Center http://www.extension.iastate.edu/agdm/crops/outlook/biodieselbalancesheet.pdf (updated 14.05.13).
30. Soybean Meal Infocenter. 2013 http://www.soymeal.org/composition.html.
31. Growmwell, G.L., Soybean meal – the “Gold Standard”. The Farmer's Pride, KPPA News, 11(20), 1999.
32. Shurtleff, W., Aoyagi, A., History of soymilk and dairy-like soymilk products. A chapter from History of Soybeans and Soyfoods: 1100 B.C. to the 1980s, 2007 (an unpublished manuscript). http://www.soyinfocenter.com/HSS/soymilk1.php.
33. Shigeki, K., Yabusaki, M., Kaga, T., Ashida, H., Yoshida, K., Identification of two major ammonia-releasing reactions involved in secondary natto fermentation. Biosci. Biotechnol. Biochem. 72:7 (2008), 1869–1976.
34. Shurtleff, W., Aoyagi, A., History of Tempeh. 1985, Published by Soyfoods Center, Lafayette, CA, USA.
35. Liem, I.T.H., Steinkraus, K.H., Cronk, T.C., Production of Vitamin B-12 in Tempeh, a fermented soybean food. Appl. Environ. Microbiol., 1977, 773–776.
36. Shurtleff, W., Aoyagi, A., The Book of Miso, Savory Soy Seasoning. 2nd edition, 2010, A Soyfoods Center Book, Ten Speed Press.
37. Shurtleff, W., Aoyagi, A., History of Soy Sauce. 2012, Soyinfo Center.
38. Sugiyama, S., Selection of micro-organisms for use in the fermentation of soy sauce. Food Microbiol. 1 (1984), 339–347.
39. Soy Protein Isolate. 2013, Soyfoods Association of North America http://www.soyfoods.org.
40. Galeaz, K., Soy Cheese, an Article on Soyfoods.com. 2013 http://www.soyfoods.com/soyfoodsdescriptions/soycheese.html.
41. Jefferson, A., Dietary phytoestrogens – a role in womens health. Nutr. Food Sci. 33:1 (2003), 16–22.
42. Liu, M.M., Huang, Y., Wang, J., Developing phytoestrogens for breast cancer prevention. Anticancer Agents Med. Chem. 12:10 (2012), 1306–1313.
43. Kaufman, P.B., Duke, J.A., Brielmann, H., Boik, J., Hoyt, J.E., A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health. J. Altern. Complement. Med. 3:1 (1997), 7–12.
44. Murphy, P.A., Song, T., Buseman, G., Isoflavones in retail and institutional soy foods. J. Agric. Food Chem. 47:7 (1999), 2697–2704.
45. Wang, H.J., Murphy, P.A., Isoflavone content in commercial soybean foods. J. Agric. Food Chem. 42:8 (1994), 1666–1673.
46. Kim, J.J., Kim, S.H., Hahn, S.J., Chung, I.M., Changing soybean isoflavone composition and concentrations under two different storage conditions over three years. Food Res. Int. 38:4 (2005), 435–444.
47. Seguin, P., Zheng, W., Smith, D.L., Deng, W., Isoflavone content of soybean cultivars grown in eastern Canada. J. Sci. Food Agric. 84:11 (2004), 1327–1332.
48. Sertovic, E., Mujic, I., Jokic, S., Alibabic, V., Saric, Z., Effect of soybean cultivars on the content of isoflavones in soymilk Romanian. Biotechnol. Lett. 17:2 (2012), 7151–7159.
49. Bhagwat, S., Haytowitz, D.B., Holden, J.M., USDA Database for the Isoflavone Content of Selected Foods. 2008, Nutrient Data Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, 25–30.
50. Winkel-Shirley, B., Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol. 126:2 (2001), 485–493.
51. Rossi, M., Amaretti, A., Roncaglia, L., Leonardi, A., Raimondi, S., Dietary isoflavones and intestinal microbiota: metabolism and transformation into bioactive compounds. Thompson, M.J., (eds.) Isoflavones: Biosynthesis, Occurrence and Health Effects, 2010, Nova Publisher, 137–161 (Chapter 4).
52. Boik, J., Dietary non-nutrient factors and their effects on cancer. Cancer and Natural Medicine: A Textbook of Basic Science and Clinical Research, 1996, Oregon Medical Press, Princeton, MN.
53. Badger, T.M., Gilchrist, J.M., Pivik, R.T., Andres, A., Shankar, K., Chen, J.R., Ronis, M.J., The health implications of soy infant formula. Am. J. Clin. Nutr. 89 (2009), 1668S–1672S.
54. Yuan, J.-P., Wang, J.-H., Liu, X., Metabolism of dietary soy isoflavones to equol by human intestinal microflora – implications for health. Mol. Nutr. Food Res. 51:7 (2007), 765–781.
55. Song, K.B., Atkinson, C., Frankenfeld, C.L., Jokela, T., Wähälä, K., Thomas, W.K., Lampe, J.W., Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J. Nutr. 136:5 (2006), 1347–1351.
56. Youlden, D.R., Cramb, S.M., Dunn, N.A., Muller, J.M., Pyke, C.M., Baade, P.D., The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 36:3 (2012), 237–248.
57. Kerrie, B., Hilakivi-Clarke, J., Genistein: does it prevent or promote breast cancer?. Environ. Health Perspect. 108:8 (2000), 701–708.
58. Wu, A.H., Ziegler, R.G., Horn-Ross, P.L., Nomura, A.M., West, D.W., Kolonel, L.N., Rosenthal, J.F., Hoover, R.N., Pike, M.C., Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol. Biomarkers Prev. 5:11 (1996), 901–906.
59. Furberg, H., Millikan, R., Dressler, L., Newman, B., Geradts, J., Tumor characteristics in African American and White women. Breast Cancer Res. Treat. 68:1 (2001), 33–43.
60. Middleton, L.P., Chen, V., Perkins, G.H., Pinn, V., Page, D., Histopathology of breast cancer among African-American women. Cancer 97:1 (2003), 253–257.
61. Newman, L.A., Bunner, S., Carolin, K., Bouwman, D., Kosir, M.A., White, M., Schwartz, A., Ethnicity related differences in the survival of young breast carcinoma patients. Cancer 95:1 (2002), 21–27.
62. Chen, W.Q., Zheng, R.S., Zeng, H.M., Zhang, S.W., Li, G.L., Wu, L.Y., He, J., Incidence and mortality of breast cancer in China, 2008. Thoracic Cancer 4:1 (2013), 59–65.
63. Linos, E., Spanos, D., Rosner, B.A., Linos, K., Hesketh, T., Qu, J.D., Gao, Y.T., Zheng, W., Colditz, G.A., Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J. Natl. Cancer Inst. 100:19 (2008), 1352–1360.
64. Shin, H.R., Joubert, C., Boniol, M., Hery, C., Ahn, S.H., Won, Y.-J., Nishino, Y., Sobue, T., Chen, C.-J., You, S.-J., Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women. Cancer Causes Control 21:11 (2010), 1777–1785.
65. Goldin, B.R., Adlercreutz, H., Gorbach, S.L., Woods, M.N., Dwyer, J.T., Conlon, T., Bohn, E., Gershoff, S.N., The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am. J. Clin. Nutr. 44:6 (1986), 945–953.
66. Pinheiro, S.P., Holmes, M.D., Pollak, M.N., Barbieri, R.L., Hankinson, S.E., Racial differences in premenopausal endogenous hormones. Cancer Epidemiol. Biomarkers Prev. 14 (2005), 2147–2153.
67. Yager, J.D., Davidson, N.E., Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354:3 (2006), 270–282.
68. Qin, L.Q., Xu, J.Y., Wang, P.Y., Hoshi, K., Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies. J. Nutr. Sci. Vitaminol. (Tokyo) 52 (2006), 428–436.
69. Guha, N., Kwan, M., Quesenberry, C., Weltzien, E., Castillo, A., Caan, B., Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res. Treat. 118:2 (2009), 395–405.
70. Shu, X.O., Zheng, Y., Cai, H., Gu, K., Chen, Z., Zheng, W., Lu, W., Soy food intake and breast cancer survival. JAMA 302:22 (2009), 2437–2443.
71. Kang, X., Zhang, Q., Wang, S., Huang, X., Jin, S., Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy. Can. Med. Assoc. J. 182:17 (2010), 1857–1862.
72. Zhang, C., Ho, S.C., Lin, F., Cheng, S., Fu, J., Chen, Y., Soy product and isoflavone intake and breast cancer risk defined by hormone receptor status. Cancer Sci. 101:2 (2010), 501–507.
73. Zhu, Y.Y., Zhou, L., Jiao, S.C., Xu, L.Z., Relationship between soy food intake and breast cancer in China. Asian Pac. J. Cancer Prev. 12 (2011), 2837–2840.
74. Kang, H.B., Zhang, Y.E., Yang, J.D., Lu, K.L., Study on soy isoflavone consumption and risk of breast cancer and survival. Asian Pac. J. Cancer Prev. 13 (2012), 995–998.
75. Zhang, Y.E., Kang, H.B., Li, B.L., Zhang, R.M., Positive effects of soy isoflavone food on survival of breast cancer patients in China. Asian Pac. J. Cancer Prev. 13 (2012), 479–482.
76. Dong, J.Y., Qin, L.Q., Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res. Treat. 125:2 (2011), 315–323.
77. Nechuta, S.J., Caan, B.J., Chen, W.Y., Lu, W., Chen, Z., Kwan, M.L., Flatt, S.W., Zheng, Y., Zheng, Pierce, J.P., Shu, X.O., Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am. J. Clin. Nutr. 96:1 (2012), 123–132.
78. Magee, P.J., Rowland, I., Soy products in the management of breast cancer. Curr. Opin. Clin. Nutr. Metab. Care 15:6 (2012), 586–591.
79. Kuiper, G.G., Lemmen, J.G., Carlsson, B., Corton, J.C., Safe, S.H., van der Saag, P.T., van der Burg, B., Gustafsson, J.A., Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:10 (1998), 4252–4263.
80. Ju, Y.H., Allred, K.F., Allred, C.D., Helferich, W.G., Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations. Carcinogenesis 27:6 (2006), 1292–1299.
81. Chen, W.F., Wong, M.S., Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J. Clin. Endocrinol. Metab. 89:5 (2004), 2351–2359.
82. Yang, X., Yang, S., McKimmey, C., Liu, B., Edgerton, S.M., Bales, W., Archer, L.T., Thor, A.D., Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation. Carcinogenesis 31:4 (2010), 695–702.
83. Helferich, W.G., Andrade, J.E., Hoagland, M.S., Phytoestrogens and breast cancer: a complex story. Inflammopharmacology 16:5 (2008), 219–226.
84. Tonetti, D.A., Zhang, Y., Zhao, H., Lim, S.B., Constantinou, A.I., The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha. Nutr. Cancer 58:2 (2007), 222–229.
85. Jiang, X., Patterson, N.M., Ling, Y., Xie, J., Helferich, W.G., Shapiro, D.J., Low concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cells. Endocrinology 149:11 (2008), 5366–5373.
86. Wood, C.E., Register, T.C., Cline, J.M., Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys. Carcinogenesis 28:4 (2007), 801–808.
87. Leung, Y.-K., Mak, P., Sazzad Hassan, S., Ho, S.-M., Estrogen receptor (ER)-β isoforms: a key to understanding ER-β signaling. Proc. Natl. Acad. Sci. U.S.A. 103:35 (2006), 13162–13167.
88. Leung, Y.K., Lee, M.T., Lam, H.M., Tarapore, P., Ho, S.M., Estrogen receptor-beta and breast cancer: translating biology into clinical practice. Steroids 77:7 (2012), 727–737.
89. Cappelletti, V., Miodini, P., Di Fronzo, G., Daidone, M.G., Modulation of estrogen receptor-beta isoforms by phytoestrogens in breast cancer cells. J. Oncol. 28:5 (2006), 1185–1191.
90. Bird, A., Perceptions of epigenetics. Nature 447:7143 (2007), 396–398.
91. Suzuki, M.M., Bird, A., A DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 9 (2008), 465–476.
92. Li, Y., Meeran, S.M., Patel, S.N., Chen, H., Hardy, T.M., Tollefsbol, T.O., Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer. Mol. Cancer 4 (2013), 12–19.
93. Fürst, R.W., Kliem, H., Meyer, H.H., Ulbrich, S.E., A differentially methylated single CpG-site is correlated with estrogen receptor alpha transcription. J. Steroid Biochem. Mol. Biol. 130:1/2 (2012), 96–104.
94. Yoshida, T., Eguchi, H., Nakachi, K., Tanimoto, K., Higashi, Y., Suemasu, K., Iino, Y., Morishita, Y., Hayashi, S., Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors. Carcinogenesis 21:12 (2000), 2193–2201.
95. Wei, J., Han, B., Mao, X.Y., Wei, M.J., Yao, F., Jin, F., Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients. Tumour Biol. 33:2 (2012), 413–420.
96. Li, Y., Chen, H., Hardy, T.M., Tollefsbol, T.O., Epigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genistein. PLoS ONE 8:1 (2013), e5436–e5439.
97. Gertz, J., Reddy, T.E., Varley, K.E., Garabedian, M.J., Myers, R.M., Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 22:11 (2012), 2153–2162.
98. Zhang, G.P., Han, D., Liu, G., Gao, S.G., Cai, X.O., Duan, R.H., Feng, X.S., Effects of soy isoflavone and endogenous oestrogen on breast cancer in MMTV-erbB2 transgenic mice. J. Int. Med. Res. 40 (2012), 2073–2082.
99. Michalik, L., Auwerx, J., Berger, J.P., Chatterjee, V.K., Glass, C.K., Gonzalez, F.J., Grimaldi, P.A., Kadowaki, T., Lazar, M.A., O'Rahilly, S., Palmer, C.N., Plutzky, J., Reddy, J.K., Spiegelman, B.M., Staels, B., Wahli, W., International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol. Rev. 58:4 (2006), 726–741.
100. Belfiore, A., Genua, M., Malaguarnera, R., PPAR-gamma agonists and their effects on IGF-I receptor signaling: implications for cancer. PPAR Res., 2009, 830501.
101. Berger, J., Moller, D.E., The mechanisms of action of PPARs. Annu. Rev. Med. 53 (2002), 409–435.
102. Feige, J.N., Gelman, L., Michalik, L., Desvergne, B., Wahli, W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog. Lipid Res. 45:2 (2006), 120–159.
103. Dang, Z.C., Audinot, V., Papapoulos, S., Boutin, J.A., Löwik, C., Boutin, J.A., Löwik, C.W., Peroxisome proliferator-activated receptor g (PPARg) as a molecular target for the soy phytoestrogen genistein. J. Biol. Chem. 278:2 (2003), 962–967.
104. Dang, Z.C., Löwik, C., Dose-dependent effects of phytoestrogens on bone: molecular mechanisms. Trends Endocrinol. Metabol. 16:5 (2005), 207–213 (review paper).
105. Dang, Z.C., Dose-dependent effects of soy phyto-oestrogen genistein on adipocytes: mechanisms of action. Obes. Rev. 10:3 (2009), 342–349.
106. Green, D., Means to an End: Apoptosis and Other Cell Death Mechanisms. 2011, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY ISBN 978-0-87969-888-1.
107. Shim, H.Y., Park, J.H., Paik, H.D., Nah, S.Y., Kim, D.S., Han, Y.S., Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain-caspase and apoptosis signaling kinase 1-p38 mitogen-activated protein kinase activation cascades. Anticancer Drugs 18:6 (2007), 649–657.
108. Ferenc, P., Solár, P., Kleban, J., Mikes, J., Fedorocko, P., Down-regulation of Bcl-2 and Akt induced by combination of photoactivated hypericin and genistein in human breast cancer cells. J. Photochem. Photobiol. B 98:1 (2010), 25–34.
109. Li, Z., Li, J., Mo, B., Hu, C., Liu, H., Qi, H., Wang, X., Xu, J., Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol. In Vitro 22:7 (2008), 1749–1753.
110. Pan, H., Zhou, W., He, W., Liu, X., Ding, Q., Ling, L., Zha, X., Wang, S., Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway. Int. J. Mol. Med. 30:2 (2012), 337–343.
111. Zhu, H., Bhaijee, F., Ishaq, N., Pepper, D.J., Backus, K., Brown, A.S., Zhou, X., Miele, L., Correlation of Notch1, pAKT and nuclear NF-κB expression in triple negative breast cancer. Am. J. Cancer Res. 3:April (2) (2013), 230–239.
112. Zhou, S., Kuang, M., Zhang, B., Zhao, L., Liang, Z., Yi, T., Huang, C., Zhao, X., Wei, Y., Autophagy in tumorigenesis and cancer therapy: Dr Jekyll or Mr Hyde?. Cancer Lett. 323:2 (2012), 115–127.
113. Lin, N.Y., Beyer, C., Gießl, A., Kireva, T., Scholtysek, C., Uderhardt, S., Munoz, L.E., Dees, C., Distler, A., Wirtz, S., Krönke, G., Spencer, B., Distler, O., Schett, G., Distler, J.H., Autophagy regulates TNFα-mediated joint destruction in experimental arthritis. Ann. Rheum. Dis. 72:5 (2013), 761–768.
114. Schwartz, L.M., Smith, S.W., Jones, M.E., Osborne, B.A., Do all programmed cell deaths occur via apoptosis?. Proc. Natl. Acad. Sci. U.S.A. 90:3 (1993), 980–984.
115. Mathew, R., Karp, C.M., Beaudoin, B., Vuong, N., Chen, G., Chen, H.Y., Bray, K., Reddy, A., Bhanot, G., Gelinas, C., Dipaola, R.S., Karantza-Wadsworth, V., White, E., Autophagy suppresses tumorigenesis through elimination of p62. Cell 137 (2009), 1062–1075.
116. Gossner, G., Choi, M., Tan, L., Fogoros, S., Griffith, K.A., Kuenker, M., Liu, J.R., Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol. Oncol. 105:1 (2007), 23–30.
117. Singletary, K., Milner, J., Diet, autophagy, and cancer: a review. Cancer Epidemiol. Biomarkers Prev. 17:7 (2008), 1596–1610.
118. Nakamura, Y., Yogosawa, S., Izutani, Y., Watanabe, H., Otsuji, E., Sakai, T., A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy. Mol. Cancer, 8, 2009, 100.
119. Pan, X., Zhang, X., Sun, H., Zhang, J., Yan, M., Zhang, H., Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells. PLoS ONE, 8(2), 2013, e56679.
120. Karantza, V., White, E., Role of autophagy in breast cancer. Autophagy 3:6 (2007), 610–613.
121. Li, Y., Luo, Q., Yuan, L., Miao, C., Mu, X., Xiao, W., Li, J., Sun, T., Ma, E., JNK-dependent Atg4 upregulation mediates asperphenamate derivative BBP-induced autophagy in MCF-7 cells. Toxicol. Appl. Pharmacol. 263:1 (2012), 21–31.